Mark A Labow

Title: Mark A Labow: Innovator in Gene Expression Control

Introduction

Mark A Labow is a distinguished inventor based in Princeton, NJ (US). He has made significant contributions to the field of genetic engineering, particularly in the development of innovative methods for controlling gene expression. His work has implications for various applications, including transgenic animals and advanced cell line development.

Latest Patents

Mark A Labow holds a patent for "Eukaryotic cells comprising a DNA sequence encoding a bacterial-viral." This invention relates to novel chimeric transactivating proteins that combine functional portions of DNA binding proteins and transcriptional activator proteins. The chimeric transactivating proteins offer several advantages, including the specific activation of gene expression in engineered genes. This technology allows for exceptionally high levels of gene expression and provides the ability to increase the expression of certain genes while repressing others. The function of these proteins can be induced by chemical agents or temperature changes, making them versatile tools in genetic research.

Career Highlights

Mark A Labow is affiliated with Princeton University, where he has been involved in groundbreaking research. His work has contributed to advancements in the understanding of gene regulation and expression, paving the way for new methodologies in genetic engineering.

Collaborations

Throughout his career, Mark has collaborated with notable colleagues, including Steven B Baim and Thomas E Shenk. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Mark A Labow's contributions to the field of genetic engineering exemplify the impact of innovative thinking on scientific advancement. His patented technologies continue to influence research and applications in gene expression control.